Publications, Pharmaceutical

Using Bioequivalence and Particle Size Distribution to Develop OINDPs

The complexity of demonstrating bioequivalence in complex locally acting orally inhaled and nasal drug products is a barrier to the successful commercialization of generics.

This paper details a study to investigate the performance of a population bioequivalence (PBE) test based on particle size distribution measurements generated by morphologically directed Raman spectroscopy. Simulations of PBE trials were conducted across a range of median particle size and span values. Trial optimization strategies are presented based on the observed data and the general applicability of the approach is underlined. Appropriate trial design can help generic developers to avoid underpowered studies when using complex in vitro techniques to demonstrate bioequivalence.

Download Publication
6 Oct 2020

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

21 May 2025

Low GWP pMDI Q&A with Aptar’s ZEN30 Futurity™ Valve Solution

Publications, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Drug Delivery Innovations, Brand Differentiation

Read More
19 May 2025

Innovations in Pulmonary Care: DPI and NPLI Lead the Way

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
23 Apr 2025

Spotlight on Emissions Reductions for A Lower CO2 Footprint in Pharmaceutical Packagi...

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Dec 2024

Optimising Preclinical Studies for Intranasal and Pulmonary Programmes

Publications, Pharmaceutical, Market Insights, Product Solutions, Drug Delivery Innovations

Read More
1 2 3 36

Request Access

Close

Requesting access to Using Bioequivalence and Particle Size Distribution to Develop OINDPs.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is for validation purposes and should be left unchanged.
Back To Top